Amarin Corp Plcuk AMRN
NASDAQ AMRN
$14.09 +0.03 (+0.21%)
At close: Aug 21, 2026 · 4:00 PM EDT

Amarin Corp Plcuk (AMRN) Enterprise Value Growth (3y) (2013 - 2026)

Amarin Corp Plcuk (AMRN) Enterprise Value Growth (3y) (2013 - 2026) Analysis & Trends

Generated on {Timestamp} © BusinessQuant.com
Generated on {Timestamp} Powered by BusinessQuant Logo

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 652.20 Bn 631.44 Bn 17.26 Bn
2 AbbVie 469.51 Bn 462.94 Bn 12.70 Bn
3 Merck 376.81 Bn 369.67 Bn 12.21 Bn
4 Novartis Ag 303.04 Bn 295.35 Bn 11.24 Bn
5 Astrazeneca 257.61 Bn 252.71 Bn 12.86 Bn
6 Amgen 237.37 Bn 223.38 Bn 7.24 Bn
7 Gilead Sciences 181.73 Bn 178.55 Bn 6.22 Bn
8 Pfizer 159.66 Bn 147.96 Bn 10.94 Bn
9 Gsk 106.24 Bn 102.07 Bn 8.24 Bn
10 Amarin Corp Plcuk 5.86 Bn 5.54 Bn 14.99 Mn

Historic Data

Download Data
DateValue
Jun 30, 2026 -0.19%
Mar 31, 2026 -0.38%
Dec 31, 2025 0.74%
Sep 30, 2025 1.91%
Jun 30, 2025 1.57%
Mar 31, 2025 8.06%
Dec 31, 2024 13.47%
Sep 30, 2024 13.91%
Jun 30, 2024 15.54%
Mar 31, 2024 15.72%
Dec 31, 2023 13.82%
Sep 30, 2023 17.05%
Jun 30, 2023 17.15%
Mar 31, 2023 17.51%
Dec 31, 2022 21.71%
Sep 30, 2022 23.31%
Jun 30, 2022 -12.19%
Mar 31, 2022 -19.76%
Dec 31, 2021 -22.14%
Sep 30, 2021 -80.20%